<?xml version="1.0" encoding="UTF-8"?>
<p>In parallel, studies are being conducted all over the world, investigating CQ and HCQ effectiveness in the prevention and treatment of SAR-CoV-2. Clinical trials were registered to the Clinicaltrials.gov from USA, Korea, Mexico, among others [
 <xref rid="B104" ref-type="bibr">104</xref>]. Interestingly, a clinical prevention study (COPCOV) is intended to administrate CQ in healthy, not previously infected by SAR-CoV-2 volunteers. CQ is to be initially given as a loading dose of 10 mg base/kg, followed by 150 mg daily (250 mg CQ phosphate salt) will be taken for 3 months [
 <xref rid="B104" ref-type="bibr">104</xref>].
</p>
